Genomic features of cervical cancer
The new study, a comprehensive analysis of the genomes of 178 primary cervical cancers, found that over 70 percent of the tumors had genomic alterations in either one or both of two important cell signaling pathways.
The new study, a comprehensive analysis of the genomes of 178 primary cervical cancers, found that over 70 percent of the tumors had genomic alterations in either one or both of two important cell signaling pathways.
The study identified genomic alterations that could guide targeted therapies and immunotherapies for cervical cancer, offering new avenues for personalized treatment.
Evidence level: Állatkísérletes. Állatmodellben vizsgálták.
Related signals
- A multinational cross-sectional study on human papillomavirus and cervical cancer knowledge, vaccination attitudes, and risk factors in the Middle East
- Screening for Cervical Cancer
- Cervical cancer: Epidemiology, risk factors and screening
- AI approach outperformed human experts in identifying cervical precancer
- Targeted treatments for cervical cancer: a review